Akebia Therapeutics, Inc. (AKBA): Price and Financial Metrics

Akebia Therapeutics, Inc. (AKBA): $1.90

0.10 (-5.00%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add AKBA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#89 of 329

in industry

AKBA Price/Volume Stats

Current price $1.90 52-week high $2.48
Prev. close $2.00 52-week low $0.80
Day low $1.67 Volume 3,406,014
Day high $1.91 Avg. volume 3,130,496
50-day MA $1.46 Dividend yield N/A
200-day MA $1.40 Market Cap 399.55M

AKBA Stock Price Chart Interactive Chart >


Akebia Therapeutics, Inc. (AKBA) Company Bio


Akebia Therapeutics focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. The company was founded in 2007 and is based in Cambridge, Massachusetts.


AKBA Latest News Stream


Event/Time News Detail
Loading, please wait...

AKBA Latest Social Stream


Loading social stream, please wait...

View Full AKBA Social Stream

AKBA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching AKBA

Here are a few links from around the web to help you further your research on Akebia Therapeutics Inc's stock as an investment opportunity:

Akebia Therapeutics Inc (AKBA) Stock Price | Nasdaq
Akebia Therapeutics Inc (AKBA) Stock Quote, History and News - Yahoo Finance
Akebia Therapeutics Inc (AKBA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!